Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry

Not Applicable

Completed

• Conditions: Schizophrenia
• Interventions: Other: insight variation measure

• Registration Number: NCT01611337
• Lead Sponsor: Centre Hospitalier Esquirol

Brief Summary

Therapeutic alliance, and drug observance are major difficulties in the care of persons presenting schizophrenic symptomatology. They appear to be linked to insight, the consciousness that one has of his troubles. Nurse care in psychiatry aims at improving it, but usually without using specific evaluation tool. Insight is usually not evaluated during care, and its evolution is also not known, although it is highly probable that a positive evolution of insight for a person in hospital correlated to an adapted and optimal care by the medical and nursing teams. The investigators do not know examples of insight evaluation during a sequence of hospital care, or any evidence of insight variation in relation to evolution abilities of some schizophrenic patients cared in hospital.

The investigators propose here to evaluate insight in people presenting schizophrenia or related troubles, at the beginning of hospitalization (I1) and 1 month later (I2), to better characterize insight variations, and identify the sociodemographic, clinical and therapeutic variables linked to it.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2012-05-29
• Study First Submitted QC: 2012-05-31
• Study Start: 2012-06
• Study First Posted: 2012-06-04
• Primary Completion: 2017-07
• Study Completion: 2017-07
• Status Verified: 2017-09
• Last Update Submitted: 2017-09-18
• Last Update Posted: 2017-09-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 205

Inclusion Criteria

• Diagnosis of schizophrenia,
• Persons requiring psychiatric care in one of the participating care unit
• I1 < 6 (absent or bad consciousness of the trouble).

Exclusion Criteria

• I1≥6
• Expression capacities incompatible with Q8 scale quotation (delirium, no understanding of the french language, mutism, contention or therapeutic isolation)
• Age under 18, absence of health care insurance

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
insight evaluation	insight variation measure	insight evaluation using the Q8 scale

Primary Outcome Measures

Name	Time	Method
number of collected data explaining insight variation between the first week of hospitalization (I1) and 1 month later (I2) in a model of logistic regression	first month after hospitalization	identification of the variables explaining insight variation when it is ≥ 1,5: social and demographic data : age, gender, marital status, study level clinical : disease duration, Positive and Negative Syndrome Scale (PANSS), type of trouble therapeutic : care and treatments received during hospitalization.

Trial Locations

Locations (2)

Centre Hospitalier La Vallette; 🇫🇷 Saint-Vaury, France

Centre Hospitalier Esquirol; 🇫🇷 Limoges, France